Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs AHSZX overlap: 34% of top holdings shared

Bottom line

How much do GGHCX and AHSZX overlap?

34% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 38.6% of GGHCX's assets and 30.5% of AHSZX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GGHCXAHSZX
Weight overlap (top 25)34%
Shared holdings9
Weight in shared holdings38.6%30.5%
Total positions8255
Expense ratio1.07%0.76%
Holdings as ofJul 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Holdings GGHCX and AHSZX have in common

Holding% of GGHCX% of AHSZXOverlap
Eli Lilly and Co.10.59%3.29%3.29%
Johnson & Johnson6.76%4.06%4.06%
UnitedHealth Group Inc.6.17%3.61%3.61%
Merck & Co., Inc.4.59%4.18%4.18%
CVS Health Corp.2.52%3.67%2.52%
Welltower Inc.2.34%4.12%2.34%
Guardant Health, Inc.2.04%1.81%1.81%
Vertex Pharmaceuticals Inc.2.01%1.80%1.80%
Thermo Fisher Scientific Inc.1.55%4.00%1.55%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. AbbVie Inc. — 4.03%
  3. Gilead Sciences, Inc. — 3.63%
  4. argenx SE — 3.24%
  5. BrightSpring Health Services, Inc. — 2.20%
  6. Royalty Pharma PLC — 2.13%
  7. Cardinal Health, Inc. — 2.10%
  8. Invesco Private Government Fund — 1.80%
  9. Axsome Therapeutics, Inc. — 1.58%
  10. Edwards Lifesciences Corp. — 1.56%
  11. Invesco Treasury Portfolio — 1.56%
  12. BridgeBio Pharma, Inc. — 1.43%
  13. Waters Corp. — 1.41%
  14. IQVIA Holdings Inc. — 1.32%
  15. U C B S.a. — 1.24%

Only in AHSZX

  1. Dreyfus Treasury Obligations Cash Management — 6.51%
  2. Impulse Dynamics Ireland — 4.27%
  3. Bruker Corp — 3.98%
  4. Illumina Inc — 3.95%
  5. Teva Pharmaceutical Industries Ltd — 3.53%
  6. Abbott Laboratories — 2.93%
  7. 10x Genomics Inc — 2.26%
  8. Novo Nordisk A/s — 2.24%
  9. Repligen Corp — 2.21%
  10. Royalty Pharma Plc — 1.94%
  11. Centene Corp — 1.91%
  12. Incyte Corp — 1.86%
  13. Pennant Group Inc (the) — 1.83%
  14. Arrowhead Pharmaceuticals Inc — 1.81%
  15. Corteva Inc — 1.65%

Asset mix

Asset typeGGHCXAHSZX
Stocks97.5%91.9%
Cash & short-term funds8.8%6.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Country mix

CountryGGHCXAHSZX
US93.5%87.0%
IL0.4%3.5%
NL3.4%—
GB3.1%1.9%
CH2.7%1.3%
DK1.1%2.2%
FR—1.6%
BE1.2%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do GGHCX and AHSZX overlap?
About 34% by weight. 9 securities appear in both funds' top 25 holdings; they make up 38.6% of GGHCX's assets and 30.5% of AHSZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and AHSZX have in common?
The largest shared holdings are Merck & Co., Inc., Johnson & Johnson, UnitedHealth Group Inc., Eli Lilly and Co., CVS Health Corp..
Should I own both GGHCX and AHSZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or AHSZX?
GGHCX is broader, with 82 positions versus 55 for AHSZX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.